- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Growing Companies With Insider Buying
Global Pharmaceuticals & Biotech Growing Companies With Insider Buying
Insider Buying Ratio of 80%-100%, with forecast growth, and a respectable return on equity.
8 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GSKGlaxoSmithKline | UK£15.35 | 1.6% | 10.7% | UK£76.9b | UK£16.79 | PE17.8x | E13.3% | 5.2% | ||
| 1093CSPC Pharmaceutical Group | HK$8.40 | 1.2% | 7.7% | HK$100.4b | HK$13.46 | PE13.7x | E8.5% | 2.0% | ||
| VRNOVerano Holdings | CA$13.69 | -6.5% | n/a | CA$5.3b | CA$39.16 | PE22.8x | E10.3% | n/a | ||
| GLENMARKGlenmark Pharmaceuticals | ₹499.05 | -6.2% | -0.8% | ₹140.8b | ₹618.00 | PE13.5x | E10.4% | 0.5% | ||
| OXBOxford Biomedica | UK£12.60 | -7.1% | 48.2% | UK£1.1b | UK£18.08 | PE58.7x | E-12.8% | n/a | ||
| 3613Beijing Tong Ren Tang Chinese Medicine | HK$10.76 | 1.1% | 18.8% | HK$9.0b | HK$14.60 | PE15.4x | E14.8% | 2.2% | ||
| 543322Glenmark Life Sciences | ₹604.05 | -3.7% | n/a | ₹74.0b | ₹821.67 | PE17.9x | E16.3% | 3.5% | ||
| SOLARASolara Active Pharma Sciences | ₹1,165.65 | 0.1% | -8.7% | ₹41.9b | ₹1,811.25 | PE20.7x | E22.6% | 0.5% |
Page 1 of 1